All Stories

  1. Reply to Takefuji: Beyond linear assumptions in pulmonary function analysis: a methodological critique of veteran health outcome models
  2. Correction: Self‑report underestimates the frequency of the acute respiratory exacerbations of COPD but is associated with BAL neutrophilia and lymphocytosis: an observational study
  3. Clinical Utility of Pulmonary Function Testing in Assessing Longitudinal Outcomes of Deployed Veterans with Preserved Spirometry
  4. Indoor Air Pollution, Computed Tomography Airway-to-Lung Ratio and Lung Function Decline: Analyses from SPIROMICS AIR
  5. Phenotypes and Trajectories of Tobacco-exposed Persons with Preserved Spirometry: Insights from Lung Volumes
  6. The Effect of Chronic Altitude Exposure on Chronic Obstructive Pulmonary Disease Outcomes in the SPIROMICS Cohort: An Observational Cohort Study
  7. Trends in All-cause Mortality among U.S. Veterans with Sarcoidosis, 2004–2022
  8. Self-report underestimates the frequency of the acute respiratory exacerbations of COPD but is associated with BAL neutrophilia and lymphocytosis: an observational study
  9. NF-κB inhibitor alpha controls SARS-CoV-2 infection in ACE2-overexpressing human airway organoids
  10. Effect of twice daily inhaled albuterol on cardiopulmonary exercise outcomes, dynamic hyperinflation, and symptoms in secondhand tobacco-exposed persons with preserved spirometry and air trapping: a randomized controlled trial
  11. Response
  12. Effect of a single one-hour teaching session about environmental pollutants and climate change on the understanding and behavioral choices of adolescents: The BREATHE pilot randomized controlled trial
  13. Screening for Exposure to Beryllium Among US Veterans With a Diagnosis of Sarcoidosis, 2002-2020
  14. Late Breaking Abstract - Lung volumes differentiate emphysema- vs. airway disease-dominant pathologies with distinct clinical features in tobacco-exposed persons with preserved spirometry in SPIROMICS
  15. Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry
  16. Lung volumes differentiate the predominance of emphysemaversusairway disease phenotype in early COPD: an observational study of the COPDGene cohort
  17. Epidemiology of Sarcoidosis in U.S. Veterans from 2003 to 2019
  18. Self-report Underestimates COPD Exacerbation Frequency but Is Associated With BAL Neutrophilia and Lymphocytosis
  19. Consensus Statements on Deployment-Related Respiratory Disease, Inclusive of Constrictive Bronchiolitis
  20. Changes in Lung Volumes with Spirometric Disease Progression in COPD
  21. A MUC5B Gene Polymorphism, rs35705950-T, Confers Protective Effects Against COVID-19 Hospitalization but Not Severe Disease or Mortality
  22. Effect of ozone on allergic airway inflammation
  23. Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study
  24. NF-κB inhibitor alpha has a cross-variant role during SARS-CoV-2 infection in ACE2-overexpressing human airway organoids
  25. Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPD
  26. Remote exposure to secondhand tobacco smoke is associated with lower exercise capacity through effects on oxygen pulse, a proxy of cardiac stroke volume
  27. Automatically Explaining Machine Learning Predictions on Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study
  28. Laryngeal Hypersensitivity in a Veteran Cohort with Remote Exposure to Tear Gas and Pepper Spray
  29. Smaller Baseline TLC and VC Differentiate Smokers with Preserved Spirometry (GOLD-0) Who Progress to More Severe Spirometric Obstruction (GOLD-2 to GOLD-4 versus GOLD-1): An Analysis of the Department of Veterans Affairs Electronic Health Records
  30. The Epidemiology of Sarcoidosis Among U.S. Veterans, 2000-2020
  31. Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD
  32. Effects of short-term increases in personal and ambient pollutant concentrations on pulmonary and cardiovascular function: A panel study analysis of the Multicenter Ozone Study in oldEr subjects (MOSES 2)
  33. Performance of a Computational Phenotyping Algorithm for Sarcoidosis Using Diagnostic Codes in Electronic Medical Records: Case Validation Study From 2 Veterans Affairs Medical Centers
  34. Automatically Explaining Machine Learning Predictions on Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study
  35. Genetic Loci Associated With COVID-19 Positivity and Hospitalization in White, Black, and Hispanic Veterans of the VA Million Veteran Program
  36. Comparative Impact of Depressive Symptoms and FEV1% on Chronic Obstructive Pulmonary Disease
  37. Polygenic predisposition to venous thromboembolism is associated with increased COVID-19 positive testing rates
  38. Effect of Ozone on Allergic Airway Inflammation
  39. Developing a Machine Learning Model to Predict Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study
  40. Forced Expiratory Flow at 25%-75% Links COPD Physiology to Emphysema and Disease Severity in the SPIROMICS Cohort
  41. Elastin Degradation and Lung Function Deterioration with Remote Secondhand Tobacco Smoke Exposure in Never-smokers
  42. Characterizing COPD Symptom Variability in the Stable State Utilizing the Evaluating Respiratory Symptoms in COPD Instrument
  43. Elastin degradation markers are elevated in never-smokers with past history of prolonged exposure to secondhand tobacco smoke and are inversely associated with their lung function
  44. Defining Resilience to Smoking-related Lung Disease: A Modified Delphi Approach from SPIROMICS
  45. Actigraphy informs distinct patient-centered outcomes in Pre-COPD
  46. A MUC5Bgene polymorphism, rs35705950-T, confers protective effects in COVID-19 infection
  47. Altitude effect on COPD in SPIROMICS cohort
  48. Classification of lung function trajectories in SPIROMICS
  49. Posture-induced changes in vital capacity are associated with COPD outcomes independent of airflow obstruction in SPIROMICS
  50. Bronchodilator responsiveness over time in SPIROMICS: Clinical characteristics
  51. Automatically Explaining Machine Learning Predictions on Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study (Preprint)
  52. Mechanism of control of the near-wall turbulence using a micro-cavity array
  53. Lung immune tone via gut-lung axis: gut-derived LPS and short-chain fatty acids’ immunometabolic regulation of lung IL-1β, FFAR2, and FFAR3 expression
  54. Ratio of FEV1/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function
  55. Performance of a Computational Phenotyping Algorithm for Sarcoidosis Using Diagnostic Codes in Electronic Medical Records: Case Validation Study From 2 Veterans Affairs Medical Centers (Preprint)
  56. Remote exposure to secondhand tobacco smoke is associated with lower exercise capacity through effects on oxygen pulse, a proxy of cardiac stroke volume
  57. Actigraphy Informs Distinct Patient-Centered Outcomes in Pre-COPD
  58. Actigraphy Informs of Distinct Patient-Centered Outcome Domains in Obstructive Lung Diseases Beyond That Measured by Respiratory Questionnaires, Lung Function, or Exercise Testing
  59. Assessment of "Percent Functional Small Airways Disease" by Parametric Response Mapping as a Potential Radiographic Biomarker of Deployment-Related Constrictive Bronchiolitis
  60. COVID-19 Infection Among Airborne Hazards Open Burn Pit Registry Participants Utilizing the VA
  61. Secondhand Smoke Alters Alveolar Macrophage Gene Expression
  62. Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium
  63. Developing a Machine Learning Model to Predict Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study (Preprint)
  64. Performance of a Computational Phenotyping Algorithm for Sarcoidosis Using Diagnostic Codes in Electronic Medical Records: A Pilot Study from Two Veterans Affairs Medical Centers
  65. Lung Volumes Changes Across GOLD Stages of COPD
  66. Lower PDL1, PDL2, and AXL Expression on Lung Myeloid Cells Suggests Inflammatory Bias in Smoking and Chronic Obstructive Pulmonary Disease
  67. Actigraphy provides additional patient-centered outcome domains beyond those measured by survey questionnaires in COPD
  68. Do Ambient Ozone or Other Pollutants Modify Effects of Controlled Ozone Exposure on Pulmonary Function?
  69. Air Trapping in Pre-COPD Contributes to Abnormal Cardiovascular Response to Exercise
  70. Association Between SVC-FVC and Clinical, Functional, and Radiologic Features in Obstructive Lung Disease
  71. Current Smoking Down-Regulates Specific Alveolar Macrophage Host Defense Gene Expression Pathways
  72. Elastin Degradation Markers Are Elevated in Never-Smokers with Past History of Prolonged Exposure to Secondhand Tobacco Smoke and Are Inversely Associated with Their Lung Function
  73. Examination of Insomnia and Other Sleep Conditions Among Deployed US Service Members
  74. FEV1SVC Ratio Below 0.7 Is Associated with Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers with Normal Spirometry
  75. Intermediate (CD14++ CD16+) Monocytes Correlate with Parametric Response Mapping of Functional Small Airways Disease: Spiromics Immunophenotyping Sub-Study
  76. Lung Volumes Differences Across GOLD Stages of COPD in VA Electronic Health Records, COPDGene, and SPIROMICS
  77. Patient-Reported Clinical Variables Associated with Significant Air Trapping in Smokers: An Analysis of the SPIROMICS Cohort
  78. Performance of Computational Phenotyping Algorithm for Sarcoidosis Using Diagnostic Codes in Electronic Medical Records: A Pilot Study from Two Veterans Affairs Medical Centers
  79. Self-Reported Sleep Apnea Among Female Us Service Members in the Airborne Hazard Open Burn Pit Registry
  80. Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS Cohort
  81. Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD
  82. Military Burn Pits
  83. <p>Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis [Corrigendum]</p>
  84. Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort
  85. Laboratory-based Intermountain Validated Exacerbation (LIVE) Score stability in patients with chronic obstructive pulmonary disease
  86. Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers
  87. Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis
  88. Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis
  89. Patterns of development of airflow limitation in smokers with preserved spirometry and air trapping phenotype in COPDGene
  90. Inspiratory capacity is associated with dyspnea, exercise capacity, and survival in COPD
  91. Lung volume comparisons between spirometry and computed tomography in SPIROMICS
  92. Ozone effects on blood biomarkers of systemic inflammation, oxidative stress, endothelial function, and thrombosis: The Multicenter Ozone Study in oldEr Subjects (MOSES)
  93. Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS
  94. Changes in Lung Volumes Across GOLD Stages of COPD: Implications for Mechanisms of Air Trapping
  95. Laboratory-Based Intermountain Validated Exacerbation (LIVE) Score and Palliative Care Referrals in Patients with Chronic Obstructive Pulmonary Disease
  96. Novel Multiplexed Plasma Biomarkers and Clinical Factors Augment Risk Assessment for Indeterminate Pulmonary Nodules in Former Smokers
  97. Radiographic Lung Volumes Predict Progression to COPD in Smokers with Preserved Spirometry in SPIROMICS
  98. Unsupervised Clustering Reveals Distinct Macrophage Phenotypes Associated with COPD and COPD Exacerbation
  99. Alignment of Inhaled Chronic Obstructive Pulmonary Disease Therapies with Published Strategies. Analysis of the Global Initiative for Chronic Obstructive Lung Disease Recommendations in SPIROMICS
  100. Back to the Box: Using Lung Volumes to Predict Susceptibility to Develop Chronic Obstructive Pulmonary Disease among Smokers
  101. Inflammatory Phenotypes Associated with Chronic Obstructive Pulmonary Disease Increase Susceptibility to Exacerbation. Lessons from Single Cell Analysis of Lung Macrophages
  102. Cardiovascular function and ozone exposure: The Multicenter Ozone Study in oldEr Subjects (MOSES)
  103. MA23.03 Risk Assessment for Indeterminate Pulmonary Nodules Using a Novel, Plasma-Protein Based Biomarker Assay
  104. E-cigarettes versus nicotine patches for perioperative smoking cessation: a pilot randomized trial
  105. Late Breaking Abstract - Effect of obesity on progression of smokers without airflow obstruction to COPD
  106. Modeling exacerbation using ozone exposure in COPD patients: CO3PD pilot study
  107. Lung volume indices predict morbidity in smokers with preserved spirometry
  108. Marijuana Use, Respiratory Symptoms, and Pulmonary Function
  109. The Laboratory-Based Intermountain Validated Exacerbation (LIVE) Score Identifies Chronic Obstructive Pulmonary Disease Patients at High Mortality Risk
  110. Lung volumes identify an at-risk group in persons with prolonged secondhand tobacco smoke exposure but without overt airflow obstruction
  111. Increasing the Resolution of Chronic Obstructive Pulmonary Disease Definition. Lessons from a Cohort with Remote but Extensive Exposure to Secondhand Tobacco Smoke
  112. Stability of Frequency of Severe Chronic Obstructive Pulmonary Disease Exacerbations and Health Care Utilization in Clinical Populations
  113. Analytical validation of a novel multi-analyte plasma test for lung nodule characterization
  114. Risk assessment for indeterminate pulmonary nodules using a novel, plasma-protein based biomarker assay
  115. Respiratory Responses to Ozone Exposure: The Multicenter Ozone Study in oldEr Subjects (MOSES)
  116. Diagnosing Chronic Obstructive Pulmonary Disease Among Afghanistan and Iraq Veterans: Veterans Affair's Concordance With Clinical Guidelines for Spirometry Administration
  117. Modeling vascular inflammation and atherogenicity after inhalation of ambient levels of ozone: exploratory lessons from transcriptomics
  118. Air trapping is associated with exercise capacity in persons without overt obstructive lung disease
  119. Asthma-COPD Overlap Syndrome- an Underdiagnosed Phenotype in Heavy Smokers
  120. Remote secondhand smoke exposure is associated with progressive airflow limitation during exercise
  121. Exposure to medium and high ambient levels of ozone causes adverse systemic inflammatory and cardiac autonomic effects
  122. Inflammatory and Repair Pathways Induced in Human Bronchoalveolar Lavage Cells with Ozone Inhalation
  123. Ozone inhalation leads to a dose-dependent increase of cytogenetic damage in human lymphocytes
  124. IQGAP1-dependent scaffold suppresses RhoA and inhibits airway smooth muscle contraction
  125. Secondhand Tobacco Smoke and COPD Risk in Smokers: A COPDGene Study Cohort Subgroup Analysis
  126. Mfge8 suppresses airway hyperresponsiveness in asthma by regulating smooth muscle contraction
  127. Identification Of Biomarkers To Monitor The Activity Of STX-100, A Humanized Anti-±v²6 Antibody, In A Phase 2a Trial In Idiopathic Pulmonary Fibrosis
  128. Oxidative Injury Due to Inhalation of Ozone Causes Dose-Dependent Cytogenetic Damage in Peripheral Blood Lymphocytes
  129. Reduced Exercise Tolerance And Pulmonary Capillary Recruitment With Remote Exposure To Secondhand Tobacco Smoke
  130. Short-Term Exposure To Ozone Causes A Dose-Dependent Reduction In Heart-Rate Variability
  131. Reduced Exercise Tolerance and Pulmonary Capillary Recruitment with Remote Secondhand Smoke Exposure
  132. Effects of Exercise on Systemic Inflammatory, Coagulatory, and Cardiac Autonomic Parameters in an Inhalational Exposure Study
  133. Polymorphism in Osteopontin Gene (SPP1) Is Associated with Asthma and Related Phenotypes in a Puerto Rican Population
  134. Secreted Osteopontin Is Highly Polymerized in Human Airways and Fragmented in Asthmatic Airway Secretions
  135. PAI-1 is an essential component of the pulmonary host response during Pseudomonas aeruginosa pneumonia in mice
  136. HIV-1 NEF In HIV-Associated Pulmonary Hypertension: Are There Lung-Specific Nef Signature Sequences?
  137. Low Prevalence of Chronic Beryllium Disease Among Workers at a Nuclear Weapons Research and Development Facility
  138. Effect Of Exposure To Ambient Levels Of Ozone On Systemic Inflammation And Coagulation
  139. Pulmonary Function Abnormalities in Never-Smoking Flight Attendants Exposed to Secondhand Tobacco Smoke in the Aircraft Cabin
  140. Osteopontin Knockout Mice Show Diminished Airway Hyperreactivity Despite Increased Eosinophilic Inflammation and IgE Production in an Experimental Model of Allergic Asthma.
  141. Osteopontin Knockout Mice Show Diminished Airway Remodeling in Response to Chronic Exposure to Ozone.
  142. Osteopontin Level in Induced Sputum Is Associated with FEV1in Asthmatic Subjects.
  143. Polymorphism in Osteopontin Gene (SPP1) Is Associated with Asthma and Decreased Lung Function.
  144. Is There an Association Between Lifetime Cumulative Exposure and Acute Pulmonary Responses to Ozone?
  145. Effects of Chronic and Acute Ozone Exposure on Lipid Peroxidation and Antioxidant Capacity in Healthy Young Adults
  146. Effects of antioxidant enzyme polymorphisms on ozone-induced lung function changes
  147. Cytogenetic damage in buccal epithelia and peripheral lymphocytes of young healthy individuals exposed to ozone
  148. Effects of Nitrogen Dioxide on Allergic Airway Responses in Subjects With Asthma
  149. Repeated Exposure to Ozone Increases Alveolar Macrophage Recruitment into Asthmatic Airways
  150. Sputum Induction and Bronchoscopy for Assessment of Ozone-Induced Airway Inflammation in Asthma
  151. Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits
  152. 765-2 Dietary L-Arginine Attenuates Macrophage Infiltration and Intimal Hyperplasia After Balloon Injury
  153. Effects of immunosuppressants FK506 and rapamycin on the heterooligomeric form of the progesterone receptor